IGRT

RADIATION4 trials

Sponsors

Tata Memorial Centre, Chinese Academy of Medical Sciences, University Hospital Tuebingen, Oncology Institute of Southern Switzerland

Conditions

Brain Metastases, AdultCancer BrainCarcinoma, HepatocellularProstate Cancer

Phase 1

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

Chinese Academy of Medical SciencesCarcinoma, Hepatocellular

Start: 2013-09-30End: 2016-12-31Target: 30Updated: 2016-01-05

Unknown Phase

Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer

Active, not recruitingNCT02302105

Tata Memorial CentreProstate Cancer

Start: 2011-11-25End: 2026-10-23Updated: 2025-02-13

Study of MR-based IGRT for Prostate Cancer

RecruitingNCT02724670

University Hospital TuebingenProstate Cancer

Start: 2016-03-31End: 2028-09-30Target: 78Updated: 2019-09-25

Hypofractionated Brain Radiationcavity

CompletedNCT03561896

Oncology Institute of Southern SwitzerlandBrain Metastases, Adult, Cancer Brain

Start: 2015-01-31End: 2024-06-18Updated: 2024-07-17

Related Papers

Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial.

2020-01-0754 citations

Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data

Acta Oncologica2018-09-2817 citations